{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:30:44Z","timestamp":1793327444226,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.canlet.2026.218905","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:10:45Z","timestamp":1792537845000},"page":"218905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["UBL3 modification reduces nuclear POLE levels to potentiate antitumor immunity in aero-upper digestive squamous cell carcinomas"],"prefix":"10.1016","volume":"662","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2904-6282","authenticated-orcid":false,"given":"Zhonglan","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8538-2524","authenticated-orcid":false,"given":"Wenbai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5344-2306","authenticated-orcid":false,"given":"Qianru","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-5669","authenticated-orcid":false,"given":"Xiaobei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4811-0685","authenticated-orcid":false,"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0437-3616","authenticated-orcid":false,"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4242-033X","authenticated-orcid":false,"given":"Zhihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7969-8025","authenticated-orcid":false,"given":"Yiqing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5270-8666","authenticated-orcid":false,"given":"Gang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218905_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ccell.2025.01.003","article-title":"Squamous cell cancers of the aero-upper digestive tract: a unified perspective on biology, genetics, and therapy","volume":"43","author":"Henick","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218905_bib2","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.canlet.2026.218905_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41571-024-00979-8","article-title":"Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions","volume":"22","author":"Wang","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218905_bib4","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(24)02226-8","article-title":"Oesophageal cancer","volume":"404","author":"Yang","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218905_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s44178-023-00056-7","article-title":"Recent advances in the mechanisms of development and the early diagnosis and treatment of esophageal cancer","volume":"2","author":"Jin","year":"2023","journal-title":"Holistic Integrative Oncology"},{"key":"10.1016\/j.canlet.2026.218905_bib6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ccell.2025.03.005","article-title":"Neoadjuvant immune checkpoint therapy: enabling insights into fundamental human immunology and clinical benefit","volume":"43","author":"Pauken","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218905_bib7","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMoa1917346","article-title":"Atezolizumab for first-line treatment of PD-L1-Selected patients with NSCLC","volume":"383","author":"Herbst","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218905_bib8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1200\/JCO.22.00975","article-title":"Durvalumab with or without tremelimumab in combination with chemotherapy as first-line therapy for metastatic non-small-cell lung cancer: the phase III POSEIDON study","volume":"41","author":"Johnson","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218905_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13046-022-02422-1","article-title":"POLE\/POLD1 mutation and tumor immunotherapy","volume":"41","author":"Ma","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218905_bib10","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1001\/jamaoncol.2019.2963","article-title":"Evaluation of POLE and POLD1 mutations as biomarkers for immunotherapy outcomes across multiple cancer types","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218905_bib11","doi-asserted-by":"crossref","first-page":"17101","DOI":"10.1073\/pnas.0907147106","article-title":"DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice","volume":"106","author":"Albertson","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218905_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2026.218905_bib13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41588-022-01108-w","article-title":"Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity","volume":"54","author":"Ma","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218905_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.annonc.2024.03.009","article-title":"Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer","volume":"35","author":"Ambrosini","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218905_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002797","article-title":"Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors","volume":"9","author":"Hwang","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218905_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2023.103594","article-title":"DNA repair deficiency and the immune microenvironment: a pathways perspective","volume":"133","author":"Zhou","year":"2024","journal-title":"DNA Repair"},{"key":"10.1016\/j.canlet.2026.218905_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2022.10.024","article-title":"Molecular testing for endometrial cancer: an SGO clinical practice statement","volume":"168","author":"Walsh","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2026.218905_bib18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218905_bib19","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1038\/s41388-021-01984-2","article-title":"POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes","volume":"40","author":"Magrin","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218905_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-biochem-093010-153308","article-title":"Ubiquitin-like proteins","volume":"81","author":"van der Veen","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.canlet.2026.218905_bib21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/acs.chemrev.6b00737","article-title":"Ubiquitin-like protein conjugation: structures, chemistry, and mechanism","volume":"118","author":"Cappadocia","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.canlet.2026.218905_bib22","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1038\/s41467-018-06197-y","article-title":"UBL3 modification influences protein sorting to small extracellular vesicles","volume":"9","author":"Ageta","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218905_bib23","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1038\/s41467-022-29524-w","article-title":"Ubiquitin-like protein 3 (UBL3) is required for MARCH ubiquitination of major histocompatibility complex class II and CD86","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218905_bib24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1089\/omi.2015.0121","article-title":"Esophageal cancer epigenomics and integrome analysis of genome-wide methylation and expression in high risk Northeast Indian population","volume":"19","author":"Singh","year":"2015","journal-title":"OMICS"},{"key":"10.1016\/j.canlet.2026.218905_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.20892\/j.issn.2095-3941.2019.0279","article-title":"Identification of a potential tumor suppressor gene, UBL3, in non-small cell lung cancer","volume":"17","author":"Zhao","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.canlet.2026.218905_bib26","article-title":"UBL3 governs VEGFR inhibitor resistance by activating NOTCH signaling in renal cell carcinoma","volume":"85","author":"Tan","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218905_bib27","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1158\/0008-5472.CAN-22-3023","article-title":"PTEN loss confers resistance to Anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells","volume":"83","author":"Exposito","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218905_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2022.12.004","article-title":"Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218905_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","article-title":"Linking tumour angiogenesis and tumour immunity","volume":"26","author":"Kabir","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218905_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trecan.2022.09.003","article-title":"How cancer cells make and respond to interferon-I","volume":"9","author":"Cheon","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218905_bib31","article-title":"Mechanisms of low MHC I expression and strategies for targeting MHC I with small molecules in cancer immunotherapy","volume":"611","author":"Kong","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218905_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218905_bib33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ccell.2022.02.013","article-title":"Immune phenotypic linkage between colorectal cancer and liver metastasis","volume":"40","author":"Liu","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218905_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41421-025-00811-2","article-title":"Spatially resolved C1QC(+) macrophage-CD4(+) T cell niche in colorectal cancer microenvironment: implications for immunotherapy response","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Discov."},{"key":"10.1016\/j.canlet.2026.218905_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41419-023-06418-3","article-title":"The P286R mutation of DNA polymerase \u03b5 activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway","volume":"15","author":"Tang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218905_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41568-018-0024-5","article-title":"Deciphering the cells of origin of squamous cell carcinomas","volume":"18","author":"S\u00e1nchez-Dan\u00e9s","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218905_bib37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.celrep.2018.03.063","article-title":"Genomic, pathway network, and immunologic features distinguishing squamous carcinomas","volume":"23","author":"Campbell","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218905_bib38","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1038\/s41467-024-46785-9","article-title":"Reciprocal inhibition between TP63 and STAT1 regulates anti-tumor immune response through interferon-\u03b3 signaling in squamous cancer","volume":"15","author":"Jiang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218905_bib39","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240758","article-title":"The MLL3\/GRHL2 complex regulates malignant transformation and anti-tumor immunity in squamous cancer","volume":"222","author":"Nam","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218905_bib40","article-title":"POLE deficiency exacerbates diesel engine exhaust-induced genomic instability and malignant transformation of bronchial epithelial cells","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218905_bib41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tcb.2023.10.005","article-title":"Fumarate hydratase as a metabolic regulator of immunity","volume":"34","author":"Peace","year":"2024","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2026.218905_bib42","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.molcel.2024.01.024","article-title":"UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity","volume":"84","author":"He","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218905_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13041-024-01131-4","article-title":"Comprehensive identification of ubiquitin-like 3 (UBL3)-interacting proteins in the mouse brain","volume":"17","author":"Ageta","year":"2024","journal-title":"Mol. Brain"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:35:37Z","timestamp":1793324137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":43,"alternative-id":["S0304383526006695"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218905","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UBL3 modification reduces nuclear POLE levels to potentiate antitumor immunity in aero-upper digestive squamous cell carcinomas","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218905"}}